Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-09 11:12 am Purchase | 2022-12-30 | 13G | BIOCRYST PHARMACEUTICALS INC BCRX | VANGUARD GROUP INC | 14,204,395 7.620% | 4,791,490 (+50.90%) | Filing History |
| 2023-02-06 09:33 am Purchase | 2022-12-31 | 13G | BIOCRYST PHARMACEUTICALS INC BCRX | STATE STREET CORP STT | 11,126,861 5.970% | 2,877,832 (+34.89%) | Filing History |
| 2023-02-03 4:27 pm Purchase | 2022-12-31 | 13G | BIOCRYST PHARMACEUTICALS INC BCRX | BlackRock, Inc. BLK | 14,918,955 8.000% | 131,560 (+0.89%) | Filing History |
| 2022-02-14 4:15 pm Purchase | 2021-12-31 | 13G | BIOCRYST PHARMACEUTICALS INC BCRX | BAKER BROS. ADVISORS LP | 18,464,744 9.950% | 285,863 (+1.57%) | Filing History |
| 2022-02-09 3:33 pm Sale | 2021-12-31 | 13G | BIOCRYST PHARMACEUTICALS INC BCRX | VANGUARD GROUP INC | 9,412,905 5.230% | -2,186,429 (-18.85%) | Filing History |
| 2022-02-09 11:33 am Purchase | 2021-12-31 | 13G | BIOCRYST PHARMACEUTICALS INC BCRX | STATE STREET CORP STT | 8,249,029 4.580% | 940,213 (+12.86%) | Filing History |
| 2022-02-01 5:08 pm Sale | 2021-12-31 | 13G | BIOCRYST PHARMACEUTICALS INC BCRX | BlackRock, Inc. BLK | 14,787,395 8.200% | -1,472,350 (-9.06%) | Filing History |